DOUGLAS E. COLTHARP - 10 Feb 2023 Form 4 Insider Report for Encompass Health Corp (EHC)

Role: EVP & Chief Financial Officer
Signature: /s/ Patrick Darby, attorney-in-fact for Mr. Coltharp
Issuer symbol: EHC
Transactions as of: 10 Feb 2023
Net transactions value: -$728,505
Form type: 4
Filing time: 13 Feb 2023, 16:02:20 UTC
Previous filing: 04 Jan 2023
Next filing: 22 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	EHC	Encompass Health Common Stock	Options Exercise	$359,153	+17,895	+34%	$20.07	70,992	10 Feb 2023	Direct
transaction	EHC	Encompass Health Common Stock	Sale	$1,087,658	-17,895	-25%	$60.78	53,097	10 Feb 2023	Direct	F1
holding	EHC	Encompass Health Common Stock						125,631	10 Feb 2023	By irrevocable trust for the benefit of children

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	EHC	Non-qualified Stock Option (Right to Buy)	Options Exercise	$0	-17,895	-100%	$0.000000^*	0	10 Feb 2023	Encompass Health Common Stock	17,895	$20.07	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.78 to $60.84, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
F2	The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.

Content

This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.78 to $60.84, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.

The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.